Government of India Revised Guidelines for Management of COVID-19 in Children and Adolescents

This document is a guideline for the management of COVID-19 in children and adolescents.


Government of India Revised Guidelines for Management of COVID-19 in Children and Adolescents - cover page
Brand
Government of India
Category
Other
Document type
Other
Language
English
Pages
7
File format
PDF
File size
989 KB
Published
19 November, 2023
Updated
19 November, 2023
MD5 checksum
88FE77E6F8BB39EF2EC771A43DC8FEC6

About this manual

This document presents revised comprehensive guidelines for the management of COVID-19 in children and adolescents (below 18 years) issued by the Government of India's Ministry of Health and Family Welfare. The guidelines were updated in January 2022 to address the surge in cases attributed to the Omicron variant of concern. Key updates include changes to the title to explicitly include adolescents, revised diagnostic criteria for Multisystem Inflammatory Syndrome in Children (MIS-C), and specific recommendations regarding the use of corticosteroids and anticoagulants.

What's inside

  • Home Isolation
  • Mainstay of Treatment
  • Investigations
  • Management of ARDS and Shock
  • Management of MIS-C
  • Diagnostic Criteria
  • Post-COVID Care

Frequently asked questions

Are antivirals recommended for children less than 18 years of age?

No, the use of antivirals or monoclonal antibodies is not recommended for children less than 18 years of age, irrespective of the severity of infection.

How should steroids be administered if used?

If steroids are used, they should be tapered over 10-14 days, subject to clinical improvement.

Download PDF (989 KB)

More Government of India Manuals


View all Government of India manuals →